- Home
- BPMC vs TKC Comparison
BPMC vs TKC Comparison
Compare BPMC & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- TKC
- Stock Information
- Founded
- BPMC 2008
- TKC 1993
- Country
- BPMC United States
- TKC Turkey
- Employees
- BPMC N/A
- TKC N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- TKC Telecommunications Equipment
- Sector
- BPMC Health Care
- TKC Telecommunications
- Exchange
- BPMC Nasdaq
- TKC Nasdaq
- Market Cap
- BPMC 5.8B
- TKC 5.2B
- IPO Year
- BPMC 2015
- TKC 2000
- Fundamental
- Price
- BPMC $84.69
- TKC $6.02
- Analyst Decision
- BPMC Buy
- TKC
- Analyst Count
- BPMC 22
- TKC 0
- Target Price
- BPMC $124.48
- TKC N/A
- AVG Volume (30 Days)
- BPMC 1.2M
- TKC 830.1K
- Earning Date
- BPMC 05-01-2025
- TKC 05-27-2025
- Dividend Yield
- BPMC N/A
- TKC 2.88%
- EPS Growth
- BPMC N/A
- TKC 29.85
- EPS
- BPMC N/A
- TKC 0.30
- Revenue
- BPMC $508,824,000.00
- TKC $4,712,370,643.00
- Revenue This Year
- BPMC $45.70
- TKC $31.26
- Revenue Next Year
- BPMC $31.83
- TKC $26.69
- P/E Ratio
- BPMC N/A
- TKC $7.98
- Revenue Growth
- BPMC 104.04
- TKC 7.77
- 52 Week Low
- BPMC $73.04
- TKC $5.49
- 52 Week High
- BPMC $121.90
- TKC $8.47
- Technical
- Relative Strength Index (RSI)
- BPMC 47.15
- TKC 41.44
- Support Level
- BPMC $78.66
- TKC $5.84
- Resistance Level
- BPMC $83.50
- TKC $6.10
- Average True Range (ATR)
- BPMC 5.00
- TKC 0.15
- MACD
- BPMC 0.20
- TKC 0.04
- Stochastic Oscillator
- BPMC 67.15
- TKC 48.21
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About TKC Turkcell Iletisim Hizmetleri AS
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, Netherlands, and Ukraine. It has three main reportable segments, Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment that derives the majority of revenue comprises mainly telecommunication and technology services activities.